Search results for "Diabetes mellitus."

showing 10 items of 2067 documents

Mucormycosis of maxillary sinus in a newly diagnosed case of diabetes mellitus

2019

Rhinocerebral mucormycosis is the third most common fungal infection after aspergillosis and candidiasis. The importance of mucormycosis has grown in recent years, as the number of patients has increased dramatically. Herein, we present a case of a newly diagnosed patient of diabetes mellitus having ulcerated palate and destruction of maxillary sinus evident on computed tomography scan. A biopsy report was suggestive of mucormycosis. Aggressive medical and surgical treatment was done along with the treatment of diabetes mellitus.

medicine.medical_specialtymedicine.diagnostic_testMaxillary sinusbusiness.industryMucormycosisGeneral MedicineNewly diagnosedmedicine.diseaseAspergillosisSurgerymedicine.anatomical_structureDiabetes mellitusBiopsymedicineSurgical treatmentbusinessRhinocerebral mucormycosisJournal of Datta Meghe Institute of Medical Sciences University
researchProduct

Prognostic impact of hypertension and carotid lesions in a five years follow-up

2005

medicine.medical_specialtymedicine.diagnostic_testbiologybusiness.industryC-reactive proteinCoronary arteriosclerosisPhysical examinationTunica intimamedicine.diseasemedicine.anatomical_structureCarotid artery plaqueBlood pressureDiabetes mellitusInternal Medicinebiology.proteinMedicineRadiologybusinessAdverse effectAmerican Journal of Hypertension
researchProduct

PO-58 - Cardiovascular risk profile in survivors of adult cancer - results from the general population study.

2016

The advancements in cancer treatment and detection of early cancer have resulted in steady increase of adult cancer survivors over the years. However, due to the long term toxic effects of chemotherapy and radiotherapy, the incidence of cardiovascular diseases (CVD) is increasing in survivors. Identifying risk factors and interventions to reduce the excess burden of CVD in this vulnerable population is urgently needed.To investigate the cardiovascular risk factors (CVRFs), inflammation and coagulation profile in cancer survivors from a large population-based study.Presence of CVRFs and laboratory markers have been compared in individuals with (n=1,359) and without (n=13,626) history of canc…

medicine.medical_specialtymedicine.diagnostic_testbiologybusiness.industrymedicine.medical_treatmentIncidence (epidemiology)CancerHematologyFibrinogenmedicine.diseaseRadiation therapy03 medical and health sciences0302 clinical medicineVon Willebrand factorDiabetes mellitusInternal medicinemedicinebiology.proteinPhysical therapyPopulation study030211 gastroenterology & hepatologybusinessLipid profilemedicine.drugThrombosis research
researchProduct

Polycythemia Vera as a Predisposing Factor for Aortic Stenosis: Prevalence and Correlation with Blood Cells Count and Mutational Status

2008

Abstract The association between Polycythemia Vera (PV) and thrombosis is multi-factorial involving the complex interaction between activated leukocytes, platelets and endothelium. Recent reports have postulated that PV patients may over express adhesive molecules on red cell surface, likely by JAK2 mutation (Wautier M et al. Blood.2007;110(3):894–901). This process activates endothelium with production of vascular growth factors and other mechanisms leading to atherosclerosis. Aortic Stenosis (AS) is the commonest valvular heart disease in western countries; its pathogenesis is mainly related to a degenerative process sharing many characteristics with atherosclerosis. At the present is not…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryImmunologyvalvular heart diseaseCell BiologyHematologyHematocritmedicine.diseaseBiochemistryThrombosisGastroenterologySurgeryStenosisPolycythemia veraDiabetes mellitusRelative riskInternal medicineHeart failuremedicinebusinessBlood
researchProduct

Assessment of Skeletal Muscle Microperfusion Using MRI

2013

Blood oxygenation level-dependent (BOLD) MRI, arterial spin labeling (ASL) and dynamic contrast enhancement (DCE) are current magnetic resonance imaging (MRI) techniques allowing the non-invasive functional assessment of peripheral microvasculature in healthy and diseased individuals. The functional imaging of skeletal muscle microvasculature helps to understand muscular and vascular physiology and alterations of microcirculation under certain pathological conditions such as peripheral arterial occlusive disease, diabetes mellitus, chronic compartment syndrome and rheumatic disorders. BOLD MRI uses blood as an endogenous contrast agent provided by the different magnetic properties of oxy- a…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industrySkeletal muscleMagnetic resonance imagingmedicine.diseasePeripheralMicrocirculationFunctional imagingmedicine.anatomical_structureInternal medicineDiabetes mellitusDynamic contrast-enhanced MRICardiologyMedicinebusinessPerfusion
researchProduct

THE METABOLIC SYNDROME IN HYPERTENSION

2019

The metabolic syndrome (MS) is currently considered to be a cluster of metabolic and cardiovascular risk factors including blood pressure elevation. A higher risk to develop hypertension in MS subjects with high-normal blood pressure has been observed and, when hypertension is established, seems to be what confers a higher cardiovascular risk on top of the risk induced by blood pressure elevation. Therefore, assessment of MS components can result in clinical utility strategy to manage hypertension based on individual risk. The main mechanisms for blood pressure elevation include overactivity of the sympathetic and the reninangiotensin system, abnormal renal sodium handling, and endothelial …

medicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedicine.diseaseInsulin resistanceBlood pressureEndocrinologyInternal medicineDiabetes mellitusPathophysiology of hypertensionAortic pressureCardiologyMedicineEndothelial dysfunctionMetabolic syndromebusinessLipid profile
researchProduct

Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer

2007

Abstract Background. Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) contribute to the invasiveness of many carcinomas. Here, we studied a possible association between cytosolic uPA and PA-1 concentrations in tumor tissue with prognosis in patients with endometrial cancer. Methods. Cytosolic concentrations of uPA and PAI-1 were determined in 69 primary endothelial adenocarcinomas using an enzyme-linked immunoassay (ELISA). A possible influence of uPA and PAI-1 was studied by multivariate Cox regression adjusting for the established clinical prognostic factors FIGO-stage, grading, depth of invasion, diabetes mellitus and age. Results. Both uPA ( …

medicine.medical_specialtymedicine.drug_classAdenocarcinomaDisease-Free SurvivalMetastasisPredictive Value of TestsGermanyInternal medicineDiabetes mellitusPlasminogen Activator Inhibitor 1Progesterone receptorBiomarkers TumormedicineHumansNeoplasm StagingUrokinasebusiness.industryProportional hazards modelEndometrial cancerObstetrics and GynecologyMiddle AgedPrognosismedicine.diseaseSurvival AnalysisUrokinase-Type Plasminogen ActivatorEndometrial NeoplasmsEndocrinologyOncologyEstrogenFemalebusinessPlasminogen activatormedicine.drugGynecologic Oncology
researchProduct

The Clinical Relevance of LDL Size and Subclasses Modulation in Patients with Type-2 Diabetes

2007

increasing evidence suggest that the "quality" rather than only the "quantity" of low density lipoproteins (LDL) exerts a great influence on the cardiovascular risk. Hypertriglyceridemia, low HDL-cholesterol and increased levels of small dense LDL characterise diabetic dyslipidemia. in subjects with type-2 diabetes LDL size seems also to represent a good marker of clinical apparent and non-apparent atherosclerosis. Recently, the Coordinating Committee of the National Cholesterol Education Program stated that high-risk patients may benefit of stronger therapeutical approaches, a category of subjects that include those with type-2 diabetes. Screening for the presence of small, dense LDL may p…

medicine.medical_specialtymedicine.drug_classEndocrinology Diabetes and MetabolismAtorvastatinPharmacologyEndocrinologyEzetimibeInternal medicineInternal MedicineHumansMedicineGemfibrozilCholesterol absorption inhibitorNational Cholesterol Education ProgramHypolipidemic Agentssmall dense LDL subclasses fibrates statins ezetimibe diabetes high-riskFenofibrateBezafibratebusiness.industryHypertriglyceridemiaGeneral Medicinemedicine.diseaseLipoproteins LDLMolecular WeightEndocrinologyDiabetes Mellitus Type 2lipids (amino acids peptides and proteins)businessmedicine.drugExperimental and Clinical Endocrinology & Diabetes
researchProduct

Effect of insulin on readmission for heart failure following a hospitalization for acute heart failure

2020

AIMS: Type 2 diabetes mellitus (T2DM) is common in patients with heart failure (HF) and is related with worse outcomes. Insulin treatment is associated with sodium and water retention, weight gain, and hypoglycaemia-all pathophysiological mechanisms related to HF decompensation. This study aimed to evaluate the association between insulin treatment and the risk of 1year readmission for HF in patients discharged for acute HF.; METHODS AND RESULTS: We prospectively included 2895 consecutive patients discharged after an episode of acute HF in a single tertiary hospital. Multivariable Cox regression, adapted for competing events, was used to assess the association between insulin treatment and …

medicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineDiabetes mellitusOriginal Research ArticlesType 2 diabetes mellitusmedicineDiseases of the circulatory (Cardiovascular) systemDecompensation030212 general & internal medicineOriginal Research ArticleEjection fractionbusiness.industryProportional hazards modelInsulinHazard ratioType 2 Diabetes MellitusAcute heart failureHospital readmissionmedicine.diseaseHeart failureRC666-701Insulin therapyCardiology and Cardiovascular Medicinebusiness
researchProduct

Antihypertensive treatment: should it be titrated to blood pressure reduction or to target organ damage regression?

2005

PURPOSE OF REVIEW The success of an antihypertensive treatment is difficult to estimate by the extent of blood pressure reduction alone. Above and beyond blood pressure values in an individual patient, it is necessary to monitor the impact of antihypertensive treatment on the development or regression of hypertension-induced early end-organ damage. The intermediate objectives or surrogate endpoints may provide additional valuable information about the level of success of a given therapy in a particular patient. Moreover, monitoring intermediate objectives may provide scientific evidence for delineating the best antihypertensive treatment. RECENT FINDINGS The importance of assessing left ven…

medicine.medical_specialtymedicine.medical_treatmentBlood PressureLeft ventricular hypertrophyEssential hypertensionInternal medicineDiabetes mellitusDiabetes MellitusInternal MedicinemedicineAlbuminuriaHumansAntihypertensive AgentsReduction (orthopedic surgery)business.industrySurrogate endpointmedicine.diseaseCarotid ArteriesBlood pressureNephrologyHypertensionCardiologyAortic pressureHypertrophy Left VentricularMicroalbuminuriabusinessCurrent Opinion in Nephrology & Hypertension
researchProduct